DNLI · Denali Therapeutics Inc. · Share Buybacks
$19.28
-0.63 (-3.16%)
At close · Oct 6
Return incl. dividend (before tax)
Market Cap
$3.25B
Shares
159.85M
Volume · Oct 6
3.67M
Avg daily vol (3M)
1.57M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-02 | — | $400,000,000 | — | — | 10-Q , filed 2026-08-06 |